Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety
Clinical trial NCT02953938 · COMPLETED
Trial details
- NCT number
- NCT02953938
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-15
- Primary completion
- 2018-12-28
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.